BRPI0518353A2 - composiÇço imunogÉnica, vÍrus de sÍndrome respiratària e reprodutiva porcina atenuado, e, mÉtodo para proteger um suÍno contra a sÍndrome respiratària e reprodutiva porcina - Google Patents

composiÇço imunogÉnica, vÍrus de sÍndrome respiratària e reprodutiva porcina atenuado, e, mÉtodo para proteger um suÍno contra a sÍndrome respiratària e reprodutiva porcina

Info

Publication number
BRPI0518353A2
BRPI0518353A2 BRPI0518353-7A BRPI0518353A BRPI0518353A2 BR PI0518353 A2 BRPI0518353 A2 BR PI0518353A2 BR PI0518353 A BRPI0518353 A BR PI0518353A BR PI0518353 A2 BRPI0518353 A2 BR PI0518353A2
Authority
BR
Brazil
Prior art keywords
porcine respiratory
reproductive syndrome
protecting
attenuated
immunogenic composition
Prior art date
Application number
BRPI0518353-7A
Other languages
English (en)
Inventor
Richard Hesse
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI0518353A2 publication Critical patent/BRPI0518353A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Abstract

COMPOSIÇçO IMUNOGÊNICA, VÍRUS DE SÍNDROME RESPIRATàRIA E REPRODUTIVA PORCINA ATENUADO, E, MÉTODO PARA PROTEGER UM SUINO CONTRA A SINDROME RESPIRATàRIA E REPRODUTIVA PORCINA. Esta invenção refere-se a duas cepas atenuadas de vírus de síndrome respiratória e reprodutiva porcina (PRRSV) e às composições imunogênicas compreendendo uma ou mais cepas de vírus atenuado de síndrome respiratória e reprodutiva porcina (PRRSV).
BRPI0518353-7A 2004-11-19 2005-11-09 composiÇço imunogÉnica, vÍrus de sÍndrome respiratària e reprodutiva porcina atenuado, e, mÉtodo para proteger um suÍno contra a sÍndrome respiratària e reprodutiva porcina BRPI0518353A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62987304P 2004-11-19 2004-11-19
US67400205P 2005-04-21 2005-04-21
PCT/US2005/040366 WO2006055331A2 (en) 2004-11-19 2005-11-09 Porcine reproductive and respiratory syndrome virus strains and compositions

Publications (1)

Publication Number Publication Date
BRPI0518353A2 true BRPI0518353A2 (pt) 2008-11-18

Family

ID=36123980

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518353-7A BRPI0518353A2 (pt) 2004-11-19 2005-11-09 composiÇço imunogÉnica, vÍrus de sÍndrome respiratària e reprodutiva porcina atenuado, e, mÉtodo para proteger um suÍno contra a sÍndrome respiratària e reprodutiva porcina

Country Status (14)

Country Link
US (1) US8178103B2 (pt)
EP (1) EP1833508B1 (pt)
JP (1) JP4750125B2 (pt)
KR (1) KR101152012B1 (pt)
CN (1) CN101084011B (pt)
AT (1) ATE479440T1 (pt)
AU (1) AU2005306781B2 (pt)
BR (1) BRPI0518353A2 (pt)
CA (1) CA2587849A1 (pt)
DE (1) DE602005023342D1 (pt)
DK (1) DK1833508T3 (pt)
MX (1) MX2007005968A (pt)
PL (1) PL1833508T3 (pt)
WO (1) WO2006055331A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0711608B8 (pt) * 2006-05-12 2021-05-25 Bharat Biotech Int Ltd composição liofilizada, uso de antígeno viral, método de tratamento ou prevenção de vírus associado, método de adaptação de um vírus de uma linhagem celular adequada
CN100523177C (zh) * 2007-01-09 2009-08-05 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合症病毒弱毒疫苗株及其应用
CN101307305B (zh) * 2008-04-30 2010-06-16 中国动物疫病预防控制中心 一种猪繁殖与呼吸综合征病毒弱毒株及免疫原性物质和疫苗
KR101345786B1 (ko) * 2010-09-09 2014-02-06 녹십자수의약품(주) 신규한 돼지생식기호흡기증후군 바이러스 및 그의 용도
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
US8765142B2 (en) * 2011-02-17 2014-07-01 Boehringer Ingelheim Vetmedica Gmbh European PRRSV strain
CN102321638B (zh) * 2011-09-06 2013-04-10 南京农业大学 一种新的猪繁殖与呼吸综合征病毒orf5修饰基因及其应用
KR101430223B1 (ko) * 2012-10-09 2014-09-25 전북대학교산학협력단 면역유도능이 증가된 돼지생식기호흡기증후군 바이러스
KR101502360B1 (ko) * 2013-03-20 2015-03-25 주식회사 옵티팜 신규한 국내형 돼지생식기호흡기증후군 바이러스
US20160303219A1 (en) * 2013-12-03 2016-10-20 Intervet Inc. Swine Vaccine Against PRRS and Lawsonia Intracellularis
CN106924726B (zh) * 2015-12-29 2021-02-09 普莱柯生物工程股份有限公司 一种用于预防猪繁殖与呼吸综合征的疫苗组合物及其制备方法和应用
CN106039302A (zh) * 2016-06-21 2016-10-26 江苏省农业科学院 猪繁殖与呼吸综合征病毒核酸疫苗及其制备方法
JP6893765B2 (ja) * 2016-07-15 2021-06-23 森山　雅美 人以外の陸上動物用のウイルス感染症に対する抗体誘導剤とその補助剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69522984T2 (de) * 1994-04-11 2002-04-25 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
ES2102971B1 (es) * 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US5976537A (en) * 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
DE69704011T2 (de) * 1996-10-09 2001-06-07 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV)
ATE474041T1 (de) 1999-04-22 2010-07-15 Us Agriculture Auf dem isolat ja-142 basierender impfstoff gegen das reproduktive-und-respiratorische syndrom beim schwein
US6406460B1 (en) 2000-07-21 2002-06-18 Agecom, Inc. System and method for automatic needle change warning
SK11282003A3 (sk) * 2001-03-09 2004-02-03 Boehringer Ingelheim Vetmedica Gmbh Oslabený európsky PRRS vírus, nukleotidová sekvencia kódujúca vírus, spôsob generovania infekčného živého oslabeného PRRS vírusu, bunková línia a farmaceutický prostriedok s jeho obsahom a jeho použitie
EP1350840B1 (en) * 2002-04-05 2012-05-09 Boehringer Ingelheim Vetmedica GmbH Adaptation sites of PRRSV

Also Published As

Publication number Publication date
WO2006055331A3 (en) 2006-08-10
CA2587849A1 (en) 2006-05-26
PL1833508T3 (pl) 2011-02-28
JP2008520238A (ja) 2008-06-19
CN101084011B (zh) 2010-06-16
EP1833508A2 (en) 2007-09-19
AU2005306781B2 (en) 2011-12-22
WO2006055331A9 (en) 2006-10-26
KR101152012B1 (ko) 2012-07-04
JP4750125B2 (ja) 2011-08-17
US8178103B2 (en) 2012-05-15
DE602005023342D1 (en) 2010-10-14
WO2006055331A2 (en) 2006-05-26
MX2007005968A (es) 2007-07-20
KR20070086084A (ko) 2007-08-27
AU2005306781A1 (en) 2006-05-26
ATE479440T1 (de) 2010-09-15
EP1833508B1 (en) 2010-09-01
CN101084011A (zh) 2007-12-05
US20090238844A1 (en) 2009-09-24
DK1833508T3 (da) 2010-12-06

Similar Documents

Publication Publication Date Title
BRPI0518353A2 (pt) composiÇço imunogÉnica, vÍrus de sÍndrome respiratària e reprodutiva porcina atenuado, e, mÉtodo para proteger um suÍno contra a sÍndrome respiratària e reprodutiva porcina
CL2008003813A1 (es) Circovirus porcino; molecula de acido nucleico que lo codifica; composicion inmunogenica que lo comprende; metodo para inmunizar un cerdo contra la infeccion virica o para prevenir el sindrome postdestete de desgaste multi-sistemico (pmsw);y metodo para determinar si un mamifero tiene o esta en riesgo de desarrollar pmsw.
PH12015500773A1 (en) Methods and compositions for live attenuated viruses
SG159542A1 (en) Compositions against sars-coronavirus and uses thereof
UA106475C2 (uk) Спосіб вакцинації свині проти високопатогенного репродуктивно-респіраторного синдрому свиней (hp prrs)
BRPI0518334A2 (pt) composiÇço de revestimento, mÉtodo de revestimento, revestimento, e, mÉtodo para preparar uma composiÇço de revestimento
TW200604343A (en) Cellular permissivity factor for viruses, and uses thereof
ATE537819T1 (de) Nutrazeutische zusammensetzungen zur behandlung von muskelschwund
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
CR8402A (es) Indazol-o-glucosidos sustitutos
MX2009008577A (es) Prevencion y tratamiento contra la enfermedad asociada a arcovirus porcion sub-clinica.
BRPI0606189A2 (pt) composição, vacina e método para proteger um animal porcino de infecção por um vìrus de prrs, célula hospedeira transfectada, método para fazer um vìrus de prrs geneticamente modificado e atenuado
CO6280496A2 (es) Pestivirus atenuados
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
TW200738788A (en) Polyorganosiloxane composition for use in unsaturated elastomer, article made therefrom, and associated method
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
UA93901C2 (ru) Вакцина против микоплазмы и вируса prrs
MX2009006396A (es) Composiciones y metodos para tratar bronquitis infecciosa.
MX2009005077A (es) Composicion absorbente para tratamiento de superficies.
TW200706173A (en) Oral composition comprising carbamylating agent
WO2010128016A3 (en) Par2 agonists for use in the treatment or prevention of influenza virus type a infections
WO2006123178A3 (en) Methods and compositions for the treatment of viral diseases
WO2022094330A3 (en) Compositions comprising tetrahydrocannabinol for treating acute respiratory failure and/or acute respiratory distress syndrome
UA102145C2 (ru) Иммуногенная композиция, которая содержит lawsonia intracellularis
WO2022268916A3 (en) Pan-coronavirus peptide vaccine

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time